US BROKER MOVES: STUB upgraded at Guggenheim; ZETA reinstated at BofA

UPGRADES

• American Tower (AMT) Upgraded to Outperform at Bernstein; PT USD 207
• Assured Guaranty (AGO) Upgraded to Buy at UBS; PT USD 94
• Credicorp (BAP) Upgraded to Buy at HSBC; PT USD 350
• Jazz Pharma (JAZZ) Upgraded to Buy at UBS; PT USD 307
• Progyny (PGNY) Upgraded to Buy at Canaccord; PT USD 30
• Stubhub (STUB) Upgraded to Buy at Guggenheim; PT USD 12.50

DOWNGRADES

• Anglogold (AU) Downgraded to Underweight at ABSA Securities; PT USD 100.82
• Biofrontera (BFRI) Downgraded to Speculative Buy at Benchmark; PT USD 3
• BofA (BAC) Downgraded to Hold at CFRA
• Citigroup (C) Downgraded to Hold at CFRA
• CrowdStrike (CRWD) Downgraded to Sell at DZ Bank; PT USD 500
• Fortinet (FTNT) Downgraded to Hold at DZ Bank; PT USD 125
• Hanover (THG) Downgraded to Market Perform at BMO; PT USD 203
• James River Group Holdin (JRVR) Downgraded to Neutral at UBS; PT USD 4.75
• Lightspeed Commerce (LSPD CN) Downgraded to Underperform at BofA
• Zspace (ZSPC) Downgraded to Market Perform at Barrington Research

INITIATIONS

• Alnylam (ALNY) Initiated at New Buy at Citi
• Ascendis Pharma (ASND) Initiated at New Buy at Citi
• BioMarin (BMRN) Initiated at New Buy at Citi
• Bridgebio (BBIO) Initiated at New Neutral at Citi
• Corpay (CPAY) Initiated at New Buy at Loop Capital; PT USD 406
• Cytokinetics (CYTK) Initiated at New Buy at Citi
• Interface (TILE) Initiated at New Buy at Benchmark; PT USD 36
• Ionis Pharma (IONS) Initiated at New Buy at Citi
• Pilgrim's Pride (PPC) Reinstated Neutral at UBS; PT USD 30
• X-Energy (XE) Initiated at New Buy at TD Cowen; PT USD 35
• X-Energy (XE) Initiated at New Hold at Jefferies; PT USD 28
• X-Energy (XE) Initiated at New Buy at UBS; PT USD 40
• X-Energy (XE) Initiated at New Overweight at Morgan Stanley; PT USD 41
• X-Energy (XE) Initiated at New Buy at Guggenheim; PT USD 57
• X-Energy (XE) Initiated at New Overweight at JPMorgan; PT USD 38
• Zeta (ZETA) Reinstated Buy at BofA; PT USD 24